AQR Arbitrage’s Nuvation Bio NUVB Stock Holding History

AQR Arbitrage’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-49,998	Closed	-$560K	–	1101
2020 Q3	$560K	Buy	+49,998	New	+$540K	0.02%	393

Other funds holding NUVB

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

CCA

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return

AQR Arbitrage's NUVB Position: Q4 2020 in Review

AQR Arbitrage sold out of Nuvation Bio (NUVB) in Q4 2020, closing a stake of 49,998 shares — an estimated $560K sold.

AQR Arbitrage first reported a position in NUVB in Q3 2020 and held it in 1 quarter. The position peaked at $560K in Q3 2020. 33 funds tracked by Wall St. Rank hold NUVB as of Q4 2020.

AQR Arbitrage reported no remaining Nuvation Bio position as of Q4 2020 after selling out during the quarter.
AQR Arbitrage sold 49,998 Nuvation Bio shares in Q4 2020, an estimated $560K.
AQR Arbitrage first reported a position in Nuvation Bio in Q3 2020 and held it in 1 quarter.
AQR Arbitrage's Nuvation Bio position peaked at $560K in Q3 2020.
33 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2020.

Based on AQR Arbitrage's 13F filing for Q4 2020, filed 16 Feb 2021.